Arrivo BioVentures LLC
Morrisville
About Arrivo BioVentures LLC
Our expertise is drug development. Whether we are developing a reformulated product, a new chemical entity, or a biologic, the team at Arrivo BioVentures has expertise in identifying regulatory strategies to expedite the path to approval and the efficient implementation of the clinical programs themselves. We coordinate with the FDA (and other regulatory bodies) early and often to gain agreement on the development programs for our products, minimizing surprises and speeding implementation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $94.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2023)
- Website: arrivobio.com
- Phone: (919)460-9500
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/arrivo-bioventures-llc-86859 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.